Ignite Creation Date:
2025-12-24 @ 2:32 PM
Ignite Modification Date:
2025-12-26 @ 12:28 AM
Study NCT ID:
NCT01551459
Status:
COMPLETED
Last Update Posted:
2019-10-29
First Post:
2012-03-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase II Study of Sunitinib Versus Dacarbazine in the Treatment of Patients With Metastatic Uveal Melanoma
Sponsor:
The Clatterbridge Cancer Centre NHS Foundation Trust
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2008-008794-55
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None